Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,37578,1527,1.01 [0.91-1.12],0.8510221480954849
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,37008,360,1.09 [0.89-1.33],0.4035936449192762
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,40977,275,0.81 [0.62-1.08],0.1489580861154423
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,28312,1281,0.96 [0.85-1.08],0.4808373390770211
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,40886,184,0.94 [0.69-1.27],0.6723876638307112
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,38349,145,0.98 [0.70-1.37],0.8878000255550496
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",42935,182,0.94 [0.69-1.28],0.6967891871705152
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42942,124,0.99 [0.69-1.41],0.9407130843509278
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,37460,94,0.85 [0.54-1.36],0.5053356482650394
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,41616,200,1.05 [0.80-1.37],0.7287264278317345
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,41544,128,0.97 [0.67-1.39],0.8594755112375264
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43060,117,0.58 [0.35-0.95],0.0319366131642022
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43063,143,0.95 [0.67-1.34],0.7615931576269255
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43053,133,0.95 [0.67-1.36],0.7940832229069511
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,42503,93,1.30 [0.97-1.74],0.0827606745951344
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",41063,682,0.97 [0.83-1.13],0.6962794580718346
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,40617,236,0.83 [0.61-1.12],0.2144644868387497
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,40850,469,0.95 [0.79-1.15],0.6292725355007538
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",34572,109,0.83 [0.54-1.30],0.420231446885025
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34553,90,0.87 [0.55-1.38],0.5542725159556576
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",34899,436,1.00 [0.82-1.21],0.9755403095011518
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",34912,449,0.98 [0.81-1.19],0.865020438757599
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19609,570,0.92 [0.77-1.10],0.3461472479284387
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15614,190,1.02 [0.77-1.36],0.886053599729516
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34552,89,0.91 [0.58-1.43],0.6891187563250574
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,38555,1300,1.01 [0.91-1.13],0.8415300953144597
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",40932,566,0.86 [0.71-1.04],0.122575960966192
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,42279,205,0.69 [0.48-0.99],0.0414538447873739
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43205,191,0.78 [0.55-1.11],0.1635950733773317
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,42739,117,0.97 [0.66-1.41],0.8689569503073715
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43209,110,0.66 [0.40-1.08],0.0995886400259575
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,43295,82,0.67 [0.38-1.19],0.1721607672978355
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,42834,504,0.76 [0.62-0.95],0.0149671158998747
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43216,191,0.63 [0.43-0.93],0.0194111604931624
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43225,152,0.90 [0.64-1.28],0.565778565888086
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43121,90,0.73 [0.44-1.23],0.2402200010163505
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",43126,89,0.72 [0.42-1.21],0.2127455278196712
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,42974,327,0.95 [0.76-1.20],0.6788137490750017
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,43240,147,0.86 [0.60-1.24],0.4275855902896519
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,43051,306,0.88 [0.69-1.13],0.3284641233694507
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of breast,23388,120,0.83 [0.56-1.25],0.3853721910046987
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,22970,852,0.94 [0.82-1.08],0.3879386892260518
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,41185,323,0.90 [0.71-1.15],0.4023320310201547
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,40639,565,1.01 [0.85-1.19],0.939702784698276
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,40639,565,1.01 [0.85-1.19],0.939702784698276
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),37511,740,1.14 [1.00-1.30],0.0499054463008101
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42366,119,1.23 [0.92-1.65],0.1590285916791439
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,42799,130,0.83 [0.56-1.24],0.3593346604406373
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,35013,1899,1.02 [0.93-1.13],0.6395790170088818
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,40788,900,0.94 [0.81-1.08],0.3704364551210902
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,39381,200,0.85 [0.62-1.18],0.3340518172093268
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41302,187,1.12 [0.86-1.47],0.4009131076591344
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39361,180,0.87 [0.63-1.22],0.4280960334807843
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,40080,899,1.00 [0.87-1.15],0.957854682106538
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,40054,873,1.01 [0.88-1.16],0.8536820853815821
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,40108,295,0.99 [0.76-1.27],0.9082829875052726
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",40111,292,0.99 [0.77-1.28],0.9306680183800108
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,34729,1615,0.99 [0.89-1.10],0.8750216920709398
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",33320,206,0.67 [0.47-0.97],0.034748251936044
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,34612,1498,1.01 [0.90-1.12],0.9138159817502304
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,33195,81,0.89 [0.55-1.45],0.6349658598253471
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",33243,129,1.04 [0.74-1.47],0.8253311375046926
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,36680,1088,0.92 [0.81-1.05],0.2408102120399319
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",35986,394,0.94 [0.76-1.17],0.5990712938424136
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",42625,290,1.02 [0.81-1.28],0.8744868354437769
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",42726,211,1.11 [0.87-1.41],0.4192692352241567
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,40302,98,0.77 [0.47-1.24],0.2742495512680065
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",43132,98,0.78 [0.49-1.26],0.3178312210292099
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",35690,98,0.77 [0.47-1.24],0.2787559574511964
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,40324,120,1.13 [0.84-1.54],0.4174683182112086
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,40224,104,0.77 [0.48-1.23],0.2750001640762778
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35690,98,1.09 [0.76-1.56],0.6471667332389206
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",36117,525,0.92 [0.77-1.11],0.3917040479820664
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression,40629,462,0.92 [0.76-1.12],0.4187222406430528
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,35720,402,0.92 [0.75-1.14],0.4513094973712795
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",35804,212,0.86 [0.64-1.17],0.3434126577452612
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,40831,110,0.73 [0.46-1.17],0.1910447273266668
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,37253,2491,0.88 [0.81-0.97],0.0077346758395332
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,33844,238,0.86 [0.65-1.14],0.2933679998207595
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43038,187,0.77 [0.54-1.08],0.1334027068629438
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,41087,800,0.92 [0.79-1.07],0.277893398207114
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,40536,249,1.02 [0.80-1.31],0.8671017872849263
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,40422,135,1.01 [0.72-1.41],0.96794708218286
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",42784,120,1.11 [0.80-1.53],0.5320665802501652
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,41929,130,1.00 [0.71-1.42],0.9873805227456048
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,40564,277,0.78 [0.58-1.04],0.0914458308735975
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,42343,211,0.80 [0.58-1.11],0.1798197965417394
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",41332,1115,0.87 [0.76-1.00],0.0481945902523252
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40424,207,0.86 [0.63-1.18],0.3572872493918655
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,40859,642,0.98 [0.83-1.15],0.793136758460705
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,42819,140,0.84 [0.57-1.23],0.3752543573530422
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,42777,98,0.86 [0.55-1.35],0.5088394767997728
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,42466,203,1.03 [0.79-1.35],0.807476337863345
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42178,629,0.95 [0.80-1.12],0.5363520880620642
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,41910,361,0.84 [0.66-1.07],0.1568828771889348
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41680,131,1.20 [0.90-1.60],0.2033659083943662
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41748,199,0.82 [0.59-1.14],0.2319273905496687
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41677,128,0.91 [0.63-1.33],0.6412088561630263
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,37295,262,1.20 [0.97-1.48],0.0979584339664978
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,37708,675,0.99 [0.84-1.16],0.9000087375690724
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,41602,343,1.12 [0.93-1.36],0.2352257510682508
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,42726,68,0.97 [0.59-1.59],0.8995032861665389
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3665,68,1.04 [0.63-1.72],0.8846892719926103
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",39129,68,0.99 [0.61-1.62],0.9782186508871732
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,42143,155,0.96 [0.69-1.35],0.821938883842702
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42069,81,0.78 [0.45-1.33],0.3616908536629175
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",42119,140,1.18 [0.89-1.56],0.2517251169836818
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42374,170,0.83 [0.58-1.18],0.29485956439645
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,43106,221,1.12 [0.88-1.42],0.3686426496675157
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,41879,179,0.84 [0.59-1.18],0.3031259548821684
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,30623,5403,0.95 [0.88-1.02],0.1289934554880295
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,42248,116,1.16 [0.84-1.58],0.3683294196150209
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",32287,3716,0.97 [0.89-1.04],0.3926825360764298
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,32326,3755,0.96 [0.89-1.04],0.2908877680844748
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28660,89,0.50 [0.27-0.92],0.0268332239808335
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",39638,1957,1.00 [0.91-1.10],0.9900943067026002
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,38852,1171,1.07 [0.96-1.20],0.2365631464659795
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41534,387,1.21 [1.02-1.44],0.0266045836827399
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,41921,774,1.13 [0.99-1.29],0.0614092980564644
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43060,162,1.10 [0.83-1.46],0.5188033575161236
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38168,487,1.04 [0.87-1.25],0.6665445174463067
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,39192,1539,0.98 [0.88-1.10],0.7414149581210014
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,41889,188,1.10 [0.84-1.43],0.4824297492462962
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42091,395,1.10 [0.92-1.32],0.3051987481110003
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,41866,165,1.30 [1.03-1.63],0.0242849827256651
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,41868,167,1.30 [1.03-1.63],0.0257426503897966
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28729,158,1.35 [1.07-1.71],0.0107442606713431
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36044,101,0.83 [0.52-1.32],0.4222949045262189
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,36146,203,1.08 [0.83-1.40],0.5841746849074654
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,23957,191,0.84 [0.60-1.17],0.3036701639958556
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,24499,733,0.97 [0.82-1.14],0.7114820579210577
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,36057,114,0.93 [0.62-1.39],0.7252654816097222
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,36102,159,1.17 [0.89-1.53],0.2542887563602561
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",41536,347,0.93 [0.74-1.18],0.5664559992923638
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",41797,253,0.65 [0.47-0.90],0.010514379886454
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",41855,213,0.72 [0.51-1.02],0.0624475551907925
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",41984,185,0.85 [0.61-1.19],0.3491213058354091
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41292,127,1.27 [0.98-1.65],0.0756430366982325
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,41386,221,0.98 [0.74-1.29],0.8835450006303889
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),40832,244,1.10 [0.88-1.39],0.4023914299150338
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,40793,205,1.22 [0.97-1.52],0.0836022320064047
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",42916,197,1.22 [0.97-1.53],0.0878722139436218
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,41395,807,1.05 [0.92-1.20],0.4480227830512859
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,41344,135,1.06 [0.77-1.46],0.7228324392849819
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,34587,3492,0.98 [0.91-1.06],0.6085192071459055
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,42963,186,0.95 [0.70-1.29],0.7456624829996361
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,40229,384,1.06 [0.87-1.29],0.5688823597491095
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",40178,333,1.05 [0.85-1.30],0.6376325585706966
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,41734,436,0.87 [0.71-1.08],0.2127775917515471
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,41727,429,0.89 [0.72-1.10],0.2997692096354208
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,41914,1031,1.02 [0.90-1.15],0.7718307140548509
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41047,164,1.04 [0.78-1.40],0.777911410065383
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,41093,210,0.94 [0.71-1.26],0.6971175480523354
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41534,651,1.03 [0.89-1.20],0.6560522343632557
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41189,306,1.15 [0.94-1.40],0.1777139849123682
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,19947,104,1.03 [0.71-1.49],0.8839820244568909
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,38635,1709,0.96 [0.86-1.06],0.3988475005677171
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,41317,297,1.11 [0.90-1.36],0.3421860192995826
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",41357,337,1.07 [0.87-1.31],0.5263045152260237
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",41357,337,1.07 [0.87-1.31],0.5263045152260237
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",40334,1405,0.95 [0.85-1.06],0.3855568510230109
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Asthma,30929,1405,0.95 [0.85-1.07],0.4038177202856784
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",30487,1405,0.95 [0.85-1.07],0.4078274674999402
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",30907,1383,0.96 [0.85-1.07],0.4496530712072589
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,42643,172,1.07 [0.81-1.43],0.6254953976990945
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,40731,134,1.08 [0.78-1.48],0.65350176817934
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",42777,134,1.08 [0.78-1.48],0.6529770631013627
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,40718,121,0.97 [0.67-1.41],0.8754531302513993
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,39809,182,0.96 [0.70-1.31],0.7830694564173242
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,40026,399,0.93 [0.75-1.15],0.5120979454713763
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,41164,185,0.84 [0.60-1.18],0.3165727404618617
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,29496,9772,0.98 [0.93-1.03],0.4158536685652518
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42396,705,0.90 [0.76-1.06],0.1916227987473754
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43231,150,0.81 [0.55-1.18],0.2636250056224501
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,43237,139,0.81 [0.55-1.20],0.2898243534826591
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,41877,186,1.07 [0.81-1.40],0.6536945412539608
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41856,165,0.84 [0.59-1.19],0.3254656451855582
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43214,167,0.85 [0.60-1.20],0.35273219634412
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,41846,155,0.75 [0.51-1.11],0.1454421539373171
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41414,129,1.00 [0.70-1.42],0.9864025548318412
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43094,89,0.95 [0.61-1.47],0.8067007916655609
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,32977,449,0.88 [0.71-1.08],0.2215110439322729
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",36170,3642,0.98 [0.92-1.06],0.6689599216070166
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,33099,571,1.02 [0.86-1.20],0.8435750327757885
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,33716,1188,0.96 [0.85-1.08],0.4860846755039913
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,32654,126,1.36 [1.08-1.72],0.0090251859092187
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,32882,354,1.18 [0.99-1.40],0.0697221620112181
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32624,96,0.84 [0.52-1.34],0.4559441276604511
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,32772,244,0.98 [0.76-1.27],0.886597304880129
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,32741,213,0.76 [0.54-1.06],0.1050165063769003
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43062,150,0.77 [0.52-1.14],0.1971122852533238
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,32738,210,0.80 [0.58-1.11],0.1877653471970307
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),33889,1361,0.96 [0.85-1.07],0.4479756308117681
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,43017,216,0.97 [0.73-1.27],0.802051806173714
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33269,741,1.03 [0.90-1.19],0.6551587265028029
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,32808,280,0.85 [0.65-1.11],0.2335463142199663
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43004,273,1.10 [0.89-1.37],0.3682774327367865
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,42976,175,0.95 [0.70-1.30],0.7597708891829509
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,37951,2726,1.01 [0.94-1.10],0.7199554212182742
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,36235,1010,1.00 [0.87-1.14],0.958859982964126
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,35429,204,0.95 [0.70-1.28],0.7278005972543806
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,35388,163,1.20 [0.93-1.55],0.1671733759020341
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,36681,1456,1.02 [0.92-1.13],0.6936130607216608
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,41648,1285,1.03 [0.93-1.15],0.5335832780802506
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,33950,3371,1.01 [0.94-1.08],0.8598917238698072
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42721,102,1.08 [0.75-1.55],0.6849594010717758
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",43177,139,1.05 [0.77-1.45],0.7452524486647844
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,40502,139,1.05 [0.77-1.45],0.7498580594359605
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40468,105,0.91 [0.60-1.38],0.6501708047467385
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",43060,234,1.03 [0.80-1.33],0.7929878732022079
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,40597,234,1.03 [0.80-1.33],0.7954504989949946
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40571,208,1.01 [0.77-1.32],0.9611357267385456
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41407,1044,1.01 [0.90-1.14],0.8445065674590502
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41395,1032,1.02 [0.90-1.15],0.8046242245621131
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,30747,168,0.94 [0.68-1.30],0.7179207492397044
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,42508,168,0.95 [0.69-1.31],0.7540603727310704
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",30691,112,0.99 [0.68-1.44],0.9562514925939246
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,31580,1001,1.02 [0.90-1.16],0.7361978242314748
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,30858,279,0.95 [0.74-1.21],0.6659381664999318
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,31051,472,1.04 [0.88-1.24],0.6499888439724995
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,40600,424,1.07 [0.89-1.28],0.490294952338024
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,42538,148,0.84 [0.58-1.21],0.3499579487401408
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30829,250,1.05 [0.83-1.33],0.6603047128031605
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30704,125,0.73 [0.47-1.14],0.1625531422261291
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32068,1489,1.05 [0.95-1.16],0.3621882338308282
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,31047,468,0.98 [0.82-1.19],0.8728200425704272
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,42515,125,0.83 [0.55-1.24],0.3601330818091829
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,41899,203,1.09 [0.84-1.41],0.5102929638480356
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,41808,112,0.98 [0.66-1.43],0.8994062550004271
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",40960,1035,0.93 [0.82-1.06],0.3019568611634332
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,40754,829,0.86 [0.73-1.00],0.0568647471993708
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,40090,165,1.14 [0.87-1.48],0.3518507172449587
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40003,78,0.88 [0.53-1.44],0.6041059971447125
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40036,111,1.07 [0.75-1.51],0.7248714534812064
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),42982,111,1.07 [0.75-1.52],0.706172218559789
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,40952,519,0.93 [0.77-1.12],0.4570725350636866
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40547,114,1.12 [0.80-1.55],0.5185066491631598
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,40528,95,1.17 [0.83-1.65],0.356285231886987
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40514,81,0.97 [0.61-1.52],0.8841907399546245
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,40767,334,0.88 [0.69-1.12],0.2870556126983633
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,40755,322,0.89 [0.69-1.14],0.3483711314947707
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,38025,2632,0.95 [0.87-1.03],0.217818276098068
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,42524,181,0.90 [0.65-1.24],0.5015850125807255
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42585,774,0.90 [0.77-1.06],0.202800912919937
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,40647,972,0.99 [0.87-1.13],0.922236698281393
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,41751,675,0.95 [0.81-1.12],0.571170779620794
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41229,153,1.03 [0.75-1.40],0.8604870588300522
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,41504,428,0.95 [0.77-1.16],0.6060659057171731
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,42805,153,1.14 [0.86-1.51],0.3551006019765017
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,42769,117,1.21 [0.90-1.63],0.2066285782251288
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42742,90,1.13 [0.78-1.63],0.5264480700763627
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41911,100,0.80 [0.50-1.27],0.3445565742642359
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42426,615,0.93 [0.79-1.11],0.418366398163888
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,39832,157,0.82 [0.57-1.19],0.2895540967400823
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39840,165,1.10 [0.84-1.45],0.4842877898232764
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39803,128,0.97 [0.68-1.38],0.8475687359221025
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40043,368,0.96 [0.78-1.19],0.7053838722472023
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40008,333,0.95 [0.76-1.19],0.6534593177811874
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,31206,6718,0.94 [0.89-1.00],0.0519700912472175
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,33921,3905,0.94 [0.87-1.01],0.091214067023373
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,38997,2045,0.95 [0.86-1.04],0.243437387204547
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30278,262,1.07 [0.85-1.34],0.551418338765537
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,30784,768,0.87 [0.74-1.02],0.0945512599715124
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",42570,251,1.09 [0.86-1.37],0.4761359816267994
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,42586,227,1.11 [0.88-1.40],0.3902466421394983
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,31942,1926,0.93 [0.84-1.03],0.1628550121914894
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",36260,1926,0.93 [0.84-1.03],0.1840728333904796
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30130,114,1.07 [0.75-1.53],0.6890446749278364
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",42347,110,1.07 [0.75-1.52],0.7120730740749577
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,30373,357,0.66 [0.50-0.87],0.0034911582291253
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,30133,117,0.96 [0.66-1.40],0.8314274509256103
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,30500,484,1.06 [0.89-1.26],0.5117458019985632
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43000,244,1.05 [0.82-1.34],0.6812045610264041
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,30901,885,0.89 [0.77-1.04],0.1459109487033531
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,30663,647,0.84 [0.70-1.00],0.0563598310227227
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,32195,2179,0.90 [0.82-0.99],0.0267148146960284
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30136,120,1.01 [0.70-1.44],0.9747234049084648
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30410,394,0.97 [0.79-1.19],0.7467869468323011
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30106,90,0.93 [0.60-1.45],0.7583626704008621
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30117,101,0.63 [0.37-1.06],0.0786338112327229
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,30831,815,0.92 [0.79-1.07],0.264940078246862
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,30722,706,0.91 [0.77-1.07],0.2359928868525918
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,33487,470,0.76 [0.61-0.95],0.0179733972957523
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42322,242,1.08 [0.85-1.36],0.5442127236940628
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42177,97,1.10 [0.76-1.58],0.6241531052234445
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,37450,111,0.90 [0.59-1.35],0.60141689215325
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,37853,514,0.96 [0.80-1.16],0.6859964288072317
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,38915,1576,0.96 [0.87-1.07],0.4987214291797874
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,37666,327,1.01 [0.82-1.26],0.8991363513356682
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,37485,146,0.88 [0.61-1.27],0.4978552269339695
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",38586,1247,0.97 [0.86-1.09],0.5653586659968559
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37424,85,0.94 [0.60-1.48],0.799020932681268
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,37745,406,0.98 [0.80-1.19],0.8228011910815899
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37512,173,0.96 [0.70-1.31],0.7929649481166056
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37466,127,1.00 [0.70-1.42],0.9959098952920098
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,37567,228,1.15 [0.92-1.45],0.2106529634499715
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37447,108,1.02 [0.70-1.47],0.9205981150326544
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,37868,529,0.92 [0.76-1.10],0.3519683755487126
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37482,530,0.91 [0.76-1.10],0.332283203023457
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37066,114,0.84 [0.55-1.28],0.4198781560290527
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37102,150,0.71 [0.47-1.07],0.0984837254131306
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37124,172,1.09 [0.83-1.43],0.5168077325121964
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37040,88,0.69 [0.40-1.19],0.1850786034289442
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37145,193,0.90 [0.65-1.24],0.5150926000192215
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37126,174,0.94 [0.68-1.30],0.7227334837212303
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37384,432,0.88 [0.71-1.09],0.2391846779233386
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37046,94,1.05 [0.71-1.54],0.8210145481459917
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37078,126,0.80 [0.52-1.22],0.3005364518562965
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37158,206,1.01 [0.77-1.32],0.9643260320507464
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37060,108,0.86 [0.56-1.32],0.4924800945335736
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",37716,764,0.95 [0.81-1.10],0.4675021631737474
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37243,291,0.95 [0.75-1.21],0.6783853753057031
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37368,416,0.87 [0.70-1.08],0.222094553470196
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,40133,294,0.81 [0.62-1.06],0.1301372820658319
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,40489,650,0.87 [0.73-1.03],0.1070672851963222
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,39919,80,0.69 [0.39-1.22],0.2049386818832764
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,39933,94,1.25 [0.91-1.72],0.1603001762524535
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40006,167,1.15 [0.88-1.49],0.3138777015105318
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,34488,7171,0.98 [0.93-1.03],0.4626236282931567
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17117,1048,0.92 [0.80-1.05],0.2259765403945177
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,39103,357,0.81 [0.63-1.04],0.0992778040972227
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,38851,105,0.71 [0.44-1.17],0.1796006846318629
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,39326,74,0.88 [0.52-1.48],0.6253297101150703
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,39328,76,0.73 [0.41-1.29],0.2790263668614998
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39344,92,1.03 [0.68-1.54],0.8978968010145084
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42660,402,0.89 [0.72-1.11],0.3160388509578832
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,42579,105,0.99 [0.67-1.46],0.944918517808152
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42548,290,0.94 [0.74-1.21],0.6383220348020304
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42402,144,0.84 [0.57-1.23],0.3775168499239559
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,39621,1764,1.00 [0.90-1.10],0.9282640137409294
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,38008,151,0.89 [0.63-1.27],0.5218749213564187
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,37991,134,0.86 [0.58-1.27],0.4415203732479482
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,38308,451,0.99 [0.82-1.20],0.8962058800370463
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38050,193,0.94 [0.70-1.27],0.69851718974423
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,39018,1161,0.99 [0.88-1.11],0.849761253618679
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16531,462,0.95 [0.78-1.17],0.6495927273051857
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16158,89,0.97 [0.62-1.51],0.8848855754718399
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16156,87,1.26 [0.91-1.74],0.1582884938008352
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16201,132,0.81 [0.54-1.22],0.3104383542376377
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16201,132,0.84 [0.56-1.25],0.3912206370750832
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16240,171,0.90 [0.64-1.26],0.5478515322259094
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23177,417,1.02 [0.85-1.23],0.8261863453062047
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22888,128,0.77 [0.51-1.17],0.2263825283582945
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22902,142,1.26 [0.97-1.62],0.0782112496959767
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22864,104,0.94 [0.63-1.40],0.7616471297427492
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23118,479,0.93 [0.77-1.12],0.4520492565350356
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22754,115,0.70 [0.44-1.11],0.1248290929785097
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22853,214,1.03 [0.80-1.33],0.8247390349992273
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21385,3943,1.02 [0.95-1.09],0.6274576205337109
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17743,301,0.92 [0.72-1.17],0.4917725513951663
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17527,85,1.07 [0.72-1.59],0.7383232137358668
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17578,136,0.67 [0.44-1.04],0.075576760464712
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18127,685,1.01 [0.87-1.17],0.9232787597997612
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17785,343,0.99 [0.80-1.22],0.9121732404933932
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18259,817,1.07 [0.94-1.22],0.3056154887107293
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17714,272,1.22 [1.01-1.48],0.0384441696012664
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17820,378,1.11 [0.92-1.34],0.266243423355696
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17527,85,1.04 [0.70-1.57],0.83216225684263
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17606,164,1.24 [0.97-1.57],0.0868711550359278
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23403,228,1.18 [0.95-1.47],0.134832029973699
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23412,216,1.16 [0.93-1.46],0.1927069320312138
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23432,117,1.18 [0.87-1.60],0.2784342053757956
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23424,129,1.21 [0.91-1.60],0.1820556142103424
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17567,125,1.13 [0.82-1.54],0.4551710059846039
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17545,103,1.12 [0.79-1.58],0.5298080806752219
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17563,121,1.02 [0.72-1.45],0.907244040946257
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23345,396,0.77 [0.61-0.98],0.0310203914310137
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18597,1155,0.92 [0.81-1.04],0.1854859365313818
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18197,755,0.93 [0.80-1.08],0.358092624183241
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23421,172,0.88 [0.63-1.22],0.431293151888475
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17838,396,0.95 [0.77-1.17],0.627566727962015
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17710,268,0.95 [0.74-1.21],0.6675388825841906
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18223,781,1.08 [0.94-1.23],0.293170008234785
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female infertility,17529,87,0.94 [0.60-1.47],0.7767103315062418
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17522,80,1.00 [0.64-1.56],0.990558456976899
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23429,723,0.82 [0.69-0.98],0.0273084669971787
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23435,988,0.94 [0.81-1.08],0.3853768145436598
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23430,384,1.13 [0.93-1.36],0.2123565345896085
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23155,109,0.82 [0.53-1.27],0.3787567756018026
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23202,156,1.27 [0.99-1.63],0.0616140217594814
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23180,134,1.11 [0.82-1.52],0.493689976068366
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23445,140,0.84 [0.58-1.23],0.3777886715600078
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23447,139,0.85 [0.59-1.24],0.4104043468695886
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23444,355,0.87 [0.68-1.10],0.2306602594737858
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23193,104,0.97 [0.65-1.44],0.8707117038977558
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23289,200,0.92 [0.68-1.24],0.5664152981310184
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22829,123,0.96 [0.67-1.38],0.8321832515686939
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22874,168,0.98 [0.73-1.33],0.915885866999801
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22908,202,0.93 [0.70-1.25],0.643421822431236
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22831,125,0.95 [0.66-1.36],0.7715756445779405
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22821,115,0.94 [0.65-1.37],0.7476078697380532
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22825,119,0.63 [0.39-1.01],0.054058687356864
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22638,191,0.78 [0.55-1.11],0.1717877039909089
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22809,362,0.79 [0.61-1.02],0.0656402816385506
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22997,550,0.95 [0.79-1.15],0.6060326733026631
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23449,143,1.06 [0.78-1.46],0.7048372474878346
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22248,110,1.06 [0.74-1.50],0.7625913755666078
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22528,81,0.88 [0.55-1.43],0.6180603185716684
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23455,277,1.11 [0.90-1.39],0.3324022709473949
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23393,215,1.14 [0.89-1.46],0.2877217952055948
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23444,208,1.07 [0.83-1.39],0.6039191090315774
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23434,198,1.10 [0.85-1.43],0.4729396158424942
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",42634,103,1.00 [0.67-1.48],0.9900447975374648
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,39114,994,1.01 [0.89-1.14],0.8830019766579831
